Pet Health Results, Sales Routes, and Safety Controls Need Checks

|17 min read
veterinarian clinic exam room vet and vet-tech conduct wellness check on medium sized dog on a table.

Theme this week

Company results, sales routes and safety controls need separate checks. Zoetis and Elanco reported opposing revenue changes, Trupanion’s subscription pets grew as total enrollment fell, and Tractor Supply and Medi-Span widened product and pharmacy access. Compare matched units and repeat orders this month, then audit records for controlled drug alerts and repeated pathogen findings.

Executive takeaways

  1. Compare units, prices and product switches within matched treatment categories this month. Zoetis reported US companion animal revenue down 11%, while Elanco reported US Pet Health revenue up 11%. The US portfolios differ for each company. 1, 3
  2. Track outside prescription requests by retailer and pharmacy through September. Tractor Supply added more than 200 pet products and offers Allivet prescriptions through its website; Medi-Span made veterinary drug checks available to pharmacy systems. 5, 6, 7
  3. Separate Trupanion subscription and other-business pet counts in the next insurance review. Subscription pets rose 5%, total enrollment fell 2%, and other-business pets declined 14.4%. 9
  4. Audit each flagged controlled drug order for a recorded review and outcome within 30 days. MWI Veterinary Supply agreed to a $100,000 settlement over allegations that a flagged oxycodone order received little review before release. 10
  5. Check Darwin’s stock, open orders and documented patient use within 48 hours. The government seeks an order that would halt production and shipping until Darwin’s meets federal rules. The court will determine the allegations. 11, 12

Signals

1. Zoetis US companion animal revenue falls while Elanco US Pet Health revenue grows

OBSERVED

On August 6, Zoetis reported $1.044 billion in second quarter 2026 US companion animal revenue. The reported revenue was 11% lower than a year earlier and fell 11% in the first quarter. 1, 2

Zoetis said weaker demand drove the decline. The company cited pet owner price concerns and competition for its skin drugs and Simparica Trio. Generic rivals hurt Cerenia and Convenia, and Librela sales also fell. 1

On August 5, Elanco reported $420 million in second quarter US Pet Health revenue. The reported revenue was 11% higher than the previous year. Global Pet Health revenue rose 12% to $718 million. Elanco said sales volume added 9% and price added 2%. It tied most of the volume gain to Zenrelia and Credelio Quattro. 3, 4

Zoetis now expects full-year company revenue to fall 1% to 3%. The company’s organic operational measure removes currency changes and some business purchases and sales. 1

Elanco now expects full-year company revenue to grow 6% to 7%. Its organic constant-currency measure removes currency changes, sold royalty revenue, and AHV International revenue since Elanco bought it on April 30, 2026. 4

The reported US growth rates differ by 22 percentage points: an 11% decline for Zoetis and an 11% increase for Elanco. Each company defines its US portfolio differently. 1, 3

VIEWPOINT

The opposing results show that demand is moving differently across products and treatment categories. Each company includes different products in their US results, so the growth rates cannot support a direct market-share comparison. New launches, price pressure, competition between branded products, and sales lost to generics could all be shaping what clinics prescribe and customers buy.

Company-wide revenue gives operators only a broad signal for local stock and demand planning. Practices, distributors, and manufacturers should compare units sold, prices, and product switches within the same treatment category and customer accounts. When one supplier gains units as another loses them, product switching becomes more likely. When competing suppliers rise or fall together, demand across the category becomes the more likely explanation.

The full-year outlooks show what each company expects across its overall business. Category-level orders and repeat orders provide stronger evidence for US product-demand forecasts.

CONFIDENCE

High — official earnings disclosures confirm the results and outlooks. Portfolio, channel, and reporting differences limit direct comparison.

ACTIONS

Independent veterinary practices

  • Compare units sold for each named drug with same category alternatives this month.
  • Log drug swaps tied to client price concerns for 30 days.

Corporate veterinary groups and clinic consolidators

  • Compare units and prices for the named drugs across clinics within 30 days.
  • Log weekly switches from each named drug to similar drugs by region this month.

Distributors, e-retail and home delivery providers

  • Track weekly orders by brand, drug class, and buyer type through September.
  • Compare buyer-level orders for Zenrelia and Credelio Quattro with established alternatives during the next buy cycle.

Manufacturers and commercial operators

  • Compare August units and prices for the named drugs with August 2025.
  • Check the companies' demand explanations against account and distributor orders this quarter.

2. Tractor Supply adds more than 200 dog and cat products

OBSERVED

On August 5, Tractor Supply announced more than 200 additions to its dog and cat assortment. The products cover food, treats, toys, meal enhancements, and everyday supplies. Freshpet refrigerated products are available at selected stores and online. 5

Tractor Supply said Smart Supply ships eligible products or makes them available for store pickup at a chosen frequency. Allivet fills one-time or recurring pet prescriptions through TractorSupply.com. Customers enter pet and veterinarian details or upload the prescription at checkout. 5

Tractor Supply described Allivet and VIP Petcare as members of its family of brands. It said VIP Petcare runs community clinics at about 2,700 retail sites across 39 states. The retail sites include 1,700 Tractor Supply stores. 5

VIEWPOINT

The wider range sits alongside Tractor Supply's repeat order program, online pharmacy, and mobile clinics. The offers could help Tractor Supply win more of each customer's pet spending.

Store-level stock, units sold, repeat orders, and use across the Tractor Supply offers remain unreported. Operators should check local placement and repeat orders before changing forecasts or account plans.

CONFIDENCE

High — Tractor Supply's official release documents the announced assortment and described services. Store-level coverage, sales, repeat orders, and cross service use need further evidence.

ACTIONS

Independent veterinary practices

  • Track written prescription requests from Allivet each week through September.
  • Record where clients buy recommended diets during follow-up calls this month.

Corporate veterinary groups and clinic consolidators

  • Map nearby Tractor Supply and VIP Petcare sites within each clinic's service area this month.
  • Compare monthly outside refill requests at mapped clinics with the network average through year end.

Distributors, e-retail and home delivery providers

  • Compare weekly orders for announced brands with July averages through September.
  • Compare first and repeat orders for added products through the next buying cycle.

Manufacturers and commercial operators

  • Check store and online placement for the company's added products this month.
  • Measure repeat orders for placed products during the next buying cycle.

3. Medi-Span offers veterinary drug checks for pharmacy systems

OBSERVED

On August 11, Wolters Kluwer announced that Medi-Span Vet Meds was available. It serves US retail pharmacies, pharmacy partners, and organizations that fill veterinary prescriptions. Pharmacies can add its veterinary drug file and safety checks to their current systems. 6

Wolters Kluwer says the file covers hundreds of brand name and generic veterinary drugs. It says the tool checks drug interactions and toxicity, and flags health conditions that may make a drug unsafe. The company said it also checks doses by species or weight for common pets and the use of human drugs in pets. 7

In July, Wolters Kluwer surveyed 2,000 US adults aged 18 or older, including 1,336 pet owners. It weighted the full sample by age, gender, household income, region, and education. The survey used the weights to reflect the US population. The release reports weights only for the full sample. 6

Of the pet owners, 75% wanted to use the same channels for pet and family prescriptions. Another 80% said access to pet-specific drug-safety information was important. The published figures leave the overlap between the two groups unknown. 6

VIEWPOINT

Pet specific safety checks in a pharmacy's usual system could reduce manual research. They could also help pharmacies fill more pet prescriptions. Wider use could increase outside prescription requests and refill-approval work for veterinary teams.

The next tests are named pharmacy users, pet prescription volume, fill time, and manual research time. Operators should measure these results before changing refill plans.

CONFIDENCE

High — official company sources confirm the launch and list the product's functions; use and operating results remain unknown. The survey note leaves recruitment, mode, full questions, margin of error, and pet-owner weights unknown.

ACTIONS

Independent veterinary practices

  • Count pet prescriptions sent to retail pharmacies each week.
  • Log approval time for each outside refill this month.

Corporate veterinary groups and clinic consolidators

  • Log each outside refill's pharmacy and approval time for 30 days.
  • Compare average approval time across pharmacies and clinics at month-end.

Distributors, e-retail and home delivery providers

  • Check whether the 20 top selling pet medicines appear in Medi-Span within 30 days.
  • Log fill time for each Medi-Span pilot prescription this quarter.

Manufacturers and commercial operators

  • Ask Wolters Kluwer which company drugs Medi-Span covers this quarter.
  • Log pharmacy-partner questions about Medi-Span coverage of company drugs each month.

4. Trupanion subscription pets grow as total enrollment falls

OBSERVED

On August 5, Trupanion reported second quarter 2026 revenue of $392.9 million across its business, up 11% from a year earlier. Trupanion operates in the US, Canada, and parts of Continental Europe. Total pets in its subscription and other-business segments fell 2% to 1,633,131 at June 30, 2026. 8, 9

Subscription pets rose 5% to 1,124,548, while subscription revenue rose 14% to $276.7 million. Trupanion's monthly average revenue per pet rose 9%, from $79.93 to $87.44. Average monthly retention rose from 98.29% to 98.37%. 9

PETMETRIX calculated 508,583 other-business pets for 2026: 1,633,131 total pets minus 1,124,548 subscription pets. The 2025 result was 594,101: 1,660,455 total pets minus 1,066,354 subscription pets. The 85,518-pet drop represents 14.4% of the 2025 result. 9

The enrollment counts include some European policies that third parties underwrite while Trupanion acts as a broker. The revenue-per-pet and retention measures exclude those policies. 9

Trupanion's other-business segment mainly underwrites policies for third parties and has lower margins than its subscription business. Pets Best is the segment's largest revenue source. The companies agreed to end their relationship after the third quarter of 2028. Trupanion expects Pets Best enrollment to keep falling as Pets Best moves policies to other underwriters. 9

VIEWPOINT

Looking only at total enrollment could make Trupanion’s business appear to be shrinking. The segment results show a shift in its business mix. The core subscription business is growing, while the lower-margin other-business portfolio is declining. The subscription business therefore provides the clearer measure of Trupanion’s underlying commercial progress.

The Pets Best transition could continue to weigh on total enrollment even as the subscription business expands. Practices and commercial partners should assess the local effect through Trupanion invoice counts and average values. These measures will show whether subscription growth is translating into more veterinary activity and revenue in their market.

CONFIDENCE

High — official filings confirm the segment results and the Pets Best end date. The pace of the runoff and practice-level use remain unmeasured.

ACTIONS

Independent veterinary practices

  • Count invoices sent to Trupanion each month through year-end.
  • Compare this quarter's average Trupanion invoice with last quarter's average.

Corporate veterinary groups and clinic consolidators

  • Compare Trupanion invoices per 1,000 visits across clinics within 30 days.
  • List each region's average Trupanion invoice at month-end this quarter.

Distributors, e-retail and home delivery providers

  • Log any insurer named on pet medicine receipt requests each week through September.
  • Compare this month's average order value for Trupanion-linked requests with last quarter's average.

Manufacturers and commercial operators

  • Ask the 10 largest practice accounts if Trupanion invoice counts changed from last quarter.
  • Split subscription and other-business pet counts in the next insurance forecast.

5. MWI agrees to pay $100,000 to resolve drug order allegations

OBSERVED

On August 5, the US Attorney's Office for the Southern District of West Virginia announced a $100,000 settlement with MWI Veterinary Supply Inc. (MWI). The allegations involve large oxycodone hydrochloride orders from a veterinarian in Putnam County, West Virginia. The office said MWI failed to identify the orders as suspicious or notify authorities. 10

MWI is registered with the Drug Enforcement Administration (DEA) to distribute controlled substances. The Controlled Substances Act requires registered distributors to use a system that finds suspicious orders. They must notify the DEA when they find one. Investigators said MWI's policy required its Diversion Control Team to review each flagged order. The team also had to record why the system flagged it. 10

Investigators said the system flagged an oxycodone order on September 13, 2022. They said a company worker released it the next day after little review. MWI then filled nine more orders for that customer without more questions or checks. The release gives conflicting totals for these orders. PETMETRIX therefore omits a combined oxycodone total from reporting. 10

VIEWPOINT

The allegation points to procedural weak spots in alerts, staff review, release rights, records, and reporting. An alert offers little protection when a reviewer can release an order after a weak check. Operators should test every step from an alert to release or DEA reporting.

CONFIDENCE

High — the official release confirms the settlement and allegations. The full agreement was unavailable, and the release's conflicting oxycodone totals are unresolved as of August 13, 2026.

ACTIONS

Independent veterinary practices

  • Review controlled drug orders that differ from the prior 90 days this month.
  • Compare controlled drug purchases with dispensing records for the past 90 days this month.

Corporate veterinary groups and clinic consolidators

  • Find clinics with controlled drug orders that differ from their prior 90 days this month.
  • Audit purchasing and dispensing records at those clinics this quarter.

Distributors, e-retail and home delivery providers

  • Audit each flagged opioid order for a recorded review and outcome within 30 days.
  • Log each reviewer, release choice, supporting record, and reporting outcome this week.

Manufacturers and commercial operators

  • Request written review steps from each controlled drug distributor this quarter.
  • Ask each distributor which records support a release at the next review.

6. Justice Department seeks to halt Darwin's pet food production

OBSERVED

On August 7, the US federal government filed a civil complaint against Gary T. Tashjian and Arrow Reliance Inc. Arrow Reliance does business as Darwin's Natural Pet Products. The complaint seeks a permanent injunction. 11, 12

The requested order would stop Darwin's from making or shipping animal food. The company could restart work once its facilities, methods, processes, and controls meet federal rules in a way accepted by the US Food and Drug Administration (FDA). The complaint alleges failures in required food safety controls and shipment of raw pet food with harmful bacteria. 11

The complaint says 12 of FDA's 18 most recent samples of Darwin's raw pet food contained pathogens. FDA collected the samples from 2023 onward. Nine contained Salmonella, one contained Listeria monocytogenes, and two contained both. A third party tested unopened packages of Darwin's raw pet food in 2025. It found Salmonella in two lots and Shiga toxin-producing E. coli in one lot. 11

The complaint also says FDA found Salmonella in an August 2024 swab from inside a hopper used to package finished raw pet food. 11

The complaint says Darwin's makes about 85,000 pounds of finished raw pet food each week and ships it across the US. It says FDA received 49 consumer complaints from 2016 through January 2026 involving pets reported sick after eating Darwin's raw pet food. It also alleges that the defendants declined several FDA recall recommendations and formal requests. 11

If the case reaches trial, the government must show its claims are more likely true than false. 12

VIEWPOINT

The requested court order creates a possible supply break for Darwin's customers. Operators that stock or recommend Darwin's may need current stock, open order, and client contact records if the court grants relief.

For raw food makers, the allegations connect product and facility findings with recall decisions. The key test is whether each finding produces a documented response with a named decision owner.

CONFIDENCE

High — the official complaint and Justice Department release confirm the filing, requested relief, and allegation wording. The federal court will determine the facts and outcome.

ACTIONS

Independent veterinary practices

  • Search patient records for documented Darwin's use within 48 hours.
  • Draft staff answers on case status and possible supply changes this week.

Corporate veterinary groups and clinic consolidators

  • Count clinics with documented Darwin's use in patient records within 7 days.
  • Standardize clinic answers about Darwin's case status and possible supply changes this week.

Distributors, e-retail and home delivery providers

  • If listed, compare Darwin's available stock with open orders within 48 hours.
  • Prepare a customer notice for use if Darwin's supply stops this week.

Manufacturers and commercial operators

  • Run a raw food recall exercise for repeated pathogen findings within 30 days.
  • Document the decision owner and response deadline for each facility pathogen finding this month.

Methodology and governance

This PULSE Edition covers developments posted or acted on from August 5 through August 12, 2026, using US Eastern Time.

Observed statements are anchored to public sources and attributed subscriber reports cited below. Viewpoints are PETMETRIX assessments that interpret commercial implications for operators. Early watch items are early hypotheses. They are not yet strong enough for a full Signal, and they include what would confirm or rule out the pattern.

PETMETRIX PULSE commercial intelligence is provided for informational use and to support lawful, independent business decisions. It is not legal, clinical, reimbursement, accounting, or financial advice. Route legal, clinical, reimbursement, accounting, and financial decisions to qualified advisers. Respect for the veterinary-client-patient relationship is mandatory.

Terms of Service | Privacy Policy | Methodology and Data Disclaimer

Glossary

Average monthly retention: Trupanion’s average of its monthly retention rates for enrolled subscription pets during the 12 months ending on the reporting date. Each rate compares pets remaining after cancellations with pets enrolled at the start of the month.

Civil complaint: A written court filing that starts a civil case, describes the alleged wrongs, and states the relief requested.

Insurance underwriting: The process an insurer uses to assess risk, decide whether to provide coverage, and set the price and terms.

Listeria monocytogenes: A foodborne bacterium that can cause listeriosis in people or animals.

Margin of error: A measure of the possible variation between a survey estimate and the value for the full population.

Monthly average revenue per pet: Trupanion’s subscription amounts billed in a period divided by total subscription pet-months. Each enrolled pet contributes one pet-month for each month enrolled.

Observed: A statement anchored in an attributable source, for example a company announcement, regulator posting, publication, data release, or market report.

Outside refill: A prescription refill filled outside the clinic or clinic-preferred pharmacy path.

Percentage point: The arithmetic difference between two percentages. A rise from 5% to 7% is 2 percentage points.

Shiga toxin-producing Escherichia coli (STEC): E. coli bacteria that produce Shiga toxin and can cause serious foodborne illness.

Subscription enrolled pets: Pets enrolled in an insurer’s subscription products at the reporting date.

Survey or panel weighting: A method that gives some records or groups more influence so a sample better represents the population or market being measured.

Veterinary drug file: A structured electronic file of veterinary drug information that pharmacy systems use for drug catalogs, prescription processing, and automated safety checks.

Viewpoint: PETMETRIX interpretation of observed facts through a commercial lens.

References

  1. Zoetis Inc. “Zoetis Announces Second Quarter 2026 Results.” Earnings release, August 6, 2026. https://investor.zoetis.com/news/news-details/2026/Zoetis-Announces-Second-Quarter-2026-Results/default.aspx
  2. Zoetis Inc. “Zoetis Announces First Quarter 2026 Results.” Earnings release, May 7, 2026. https://investor.zoetis.com/news/news-details/2026/Zoetis-Announces-First-Quarter-2026-Results/
  3. Elanco Animal Health Incorporated. “2026 Earnings – Second Quarter.” Investor presentation, August 5, 2026. https://investor.elanco.com/static-files/e4941243-eb84-4f4d-893d-218af49a3060
  4. Elanco Animal Health Incorporated. “Elanco Animal Health Reports Second Quarter 2026 Results.” Earnings release, August 5, 2026. https://investor.elanco.com/news-releases/news-release-details/elanco-animal-health-reports-second-quarter-2026-results
  5. Tractor Supply Company. “Tractor Supply Expands Pet Assortment With More Than 200 New Dog and Cat Products.” Company news release, August 5, 2026. https://corporate.tractorsupply.com/newsroom/news-releases/news-releases-details/2026/Tractor-Supply-Expands-Pet-Assortment-With-More-Than-200-New-Dog-and-Cat-Products/default.aspx
  6. Wolters Kluwer Health. “Wolters Kluwer brings trusted Medi-Span medication intelligence to growing veterinary drug market.” Press release, August 11, 2026. https://www.wolterskluwer.com/en/news/wolters-kluwer-brings-trusted-medi-span-medication-intelligence-to-growing-veterinary-drug-market
  7. Wolters Kluwer Health. “Medi-Span Vet Meds.” Product page, n.d.; accessed August 12, 2026. https://www.wolterskluwer.com/en/solutions/medi-span/vet-meds
  8. Trupanion, Inc. “Trupanion Reports Second Quarter 2026 Results; Authorizes Share Repurchase Program.” Exhibit 99.1 to Form 8-K, filed August 5, 2026. https://www.sec.gov/Archives/edgar/data/1371285/000137128526000171/ex991q22026.htm
  9. Trupanion, Inc. “Form 10-Q for the Quarterly Period Ended June 30, 2026.” Form 10-Q, filed August 5, 2026. https://www.sec.gov/Archives/edgar/data/1371285/000137128526000172/trup-20260630.htm
  10. US Attorney's Office for the Southern District of West Virginia. “Global Veterinary Drug Distributor Agrees to $100,000 Settlement.” Press release, August 5, 2026. https://www.justice.gov/usao-sdwv/pr/global-veterinary-drug-distributor-agrees-100000-settlement
  11. US Department of Justice, Civil Division. “Complaint for Permanent Injunction, United States v. Arrow Reliance Inc. d/b/a Darwin's Natural Pet Products and Gary T. Tashjian, Case No. 2:26-cv-02805.” Civil complaint, filed August 7, 2026. https://www.justice.gov/opa/media/1457006/dl
  12. US Department of Justice, Office of Public Affairs. “Justice Department Files Complaint to Stop Washington Firm from Manufacturing and Selling Adulterated Food Products.” Press release, August 11, 2026. https://www.justice.gov/opa/pr/justice-department-files-complaint-stop-washington-firm-manufacturing-and-selling-0